Services are often outsourced to third party vendors for certain clinical trial activities, particularly where a clinical trial activity must be standardised. Such vendor services can include a centralised review of imaging data, central pathology or laboratory analysis and Investigational Product logistics. Following the decision to outsource a service to a third-party vendor for a […]
AusTrade’s latest Clinical Trials Capability Report has some interesting facts n figures Between 2012 and 2015, phase I activity has grown by 17.2% in Australia, compared to 1.8% globally Between 2012 and 2015, phase I activity has grown by 17.2% in Australia, compared to 1.8% globally In early phase clinical trials, Australia is 28% cheaper […]
We are please to report that AbilityMate has won the 2017 National Disability Excellence in Innovation Award “We’re living in an era of design where human invention, empowered by technology could reshape the lives of people with disabilities for the better.” Melissa Fuller, co-founder AbilityMate AbilityMate is a social enterprise that combines the power of […]
The Directors of Mobius Medical attended Medtech’s Got Talent Gala Dinner last week to listen to thirteen semi-finalists pitch their incredible ideas to a well dressed and excited audience. Delighted to be on the table of one of the winners, Murray McDonald of MUVi as well as their mentors from D+I, they felt like winners […]
What is Risk Based Monitoring? Risk based monitoring is a new monitoring model that has been accepted by the European Medicines Agency and the Food and Drug Administration. It is an innovative risk based approach that focuses on critical study parameters and relies on a combination of monitoring and analytics to oversee patient safety and […]
Mobius Medical, like many other CROs all over the world, is privileged to be involved in the development of a myriad of novel innovations, and life changing medical devices, diagnostic tools and medicines. We are in the business of providing clinical trials management, strategic advice and digital solutions to the inventors and manufacturers of these […]
Since the GCP (E6 R1) was first released in 1996, clinical trials have evolved substantially in complexity, technological capabilities, and costs. ICH E6(R1) has been amended to encourage implementation of improved and more efficient approaches to clinical trial design, conduct, oversight, recording, and reporting while continuing to ensure human subject protection and reliability of trial […]
We are excited to announce the opening of our new office in Melbourne Melbourne is globally recognised as a leading Biotech innovation hub and Mobius has several large projects running at many research centres there. Mobius Medical Pty Ltd | Melbourne Level 4, 99 Commercial Road Melbourne VIC 3004 Australia Tel +61 3 8595 0970
For many years, Australia has been the one of the most attractive countries to perform clinical investigations for medical devices, pharmaceuticals and in-vitro diagnostics. The Clinical Notification Scheme (CTN) is a straight-forward and fast approval process from the Australian government regulatory organisation, Therapeutic Goods Administration (TGA). As part of the requirement of CTN, and before […]